Skip to main content

Advertisement

Log in

Heterogeneity of glioblastoma with gliomatosis cerebri growth pattern on diffusion and perfusion MRI

  • Clinical Study
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Background and purpose

Gliomatosis cerebri (GC) is a rare growth pattern of glioblastoma whose diffuse nature is reflected by unspecific, relatively uniform findings on conventional MRI. In the present study we sought to evaluate the additional value of diffusion (DWI) and perfusion weighted (PWI) MRI for a more detailed characterization.

Methods

We analyzed the MRI findings in patients with histologically proven glioblastoma with GC growth pattern with a specific emphasis on T2 lesion pattern, volume, relative apparent diffusion coefficient (rACD), and relative cerebral blood volume (rCBV) and compared these to age-/gender-matched patients with localized glioblastoma.

Results

Overall, 16 patients (median age 59.5 years, 4 male) were included in the study. Of these, 8 patients had a glioblastoma with GC growth pattern, and 8 a classical localized growth pattern. While the median rADC (1.27 [IQR 1.12–1.41]) within the T2 lesion was significant lower in glioblastoma with GC growth pattern compared to localized glioblastoma (1.74 [IQR 1.45–1.96]; p = 0.003), the median T2 lesion volume and rCBV within the T2 lesion did not differ significantly. Furthermore, six patients with glioblastoma with GC growth pattern showed focal areas with significantly reduced rADC (p = 0.043), and/or increased rCBV (p = 0.028).

Conclusions

Lower rADC in glioblastoma with GC growth pattern might reflect the diffuse tumor cell infiltration whereas focal areas with decreased rADC and/or increased rCBV probably indicate high tumor cell density and/or abnormal tumor vessels which may be useful for biopsy guidance.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987–996

    Article  PubMed  CAS  Google Scholar 

  2. Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B, Belanger K, Hau P, Brandes AA, Gijtenbeek J, Marosi C, Vecht CJ, Mokhtari K, Wesseling P, Villa S, Eisenhauer E, Gorlia T, Weller M, Lacombe D, Cairncross JG, Mirimanoff RO (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10(5):459–466

    Article  PubMed  CAS  Google Scholar 

  3. Scherer J (1940) The forms of growth in gliomas and their practical significance. Brain 40:631–635

    Google Scholar 

  4. Holland EC (2000) Glioblastoma multiforme: the terminator. Proc Natl Acad Sci USA 97(12):6242–6244

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  5. Thomas RP, Xu LW, Lober RM, Li G, Nagpal S (2013) The incidence and significance of multiple lesions in glioblastoma. J Neurooncol 112(1):91–97

    Article  PubMed  Google Scholar 

  6. Wesseling P, Capper D (2018) WHO 2016 classification of gliomas. Neuropathol Appl Neurobiol 44(2):139–150

    Article  PubMed  CAS  Google Scholar 

  7. Carpio-O’Donovan R, Korah I, Salazar A, Melancon D (1996) Gliomatosis cerebri. Radiology 198(3):831–835

    Article  PubMed  Google Scholar 

  8. Chen S, Tanaka S, Giannini C, Morris J, Yan ES, Buckner J, Lachance DH, Parney IF (2013) Gliomatosis cerebri: clinical characteristics, management, and outcomes. J Neurooncol 112(2):267–275

    Article  PubMed  PubMed Central  Google Scholar 

  9. Barajas RF Jr, Hodgson JG, Chang JS, Vandenberg SR, Yeh RF, Parsa AT, McDermott MW, Berger MS, Dillon WP, Cha S (2010) Glioblastoma multiforme regional genetic and cellular expression patterns: influence on anatomic and physiologic MR imaging. Radiology 254(2):564–576

    Article  PubMed  PubMed Central  Google Scholar 

  10. Barajas RF Jr, Phillips JJ, Parvataneni R, Molinaro A, Essock-Burns E, Bourne G, Parsa AT, Aghi MK, McDermott MW, Berger MS, Cha S, Chang SM, Nelson SJ (2012) Regional variation in histopathologic features of tumor specimens from treatment-naive glioblastoma correlates with anatomic and physiologic MR Imaging. Neuro Oncology 14(7):942–954

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  11. Peretti-Viton P, Brunel H, Chinot O, Daniel C, Barrie M, Bouvier C, Figarella-Branger D, Fuentes S, Dufour H, Grisoli F (2002) Histological and MR correlations in Gliomatosis cerebri. J Neurooncol 59(3):249–259

    Article  PubMed  Google Scholar 

  12. Gempt J, Soehngen E, Forster S, Ryang YM, Schlegel J, Zimmer C, Meyer B, Ringel F, Grams AE, Forschler A (2014) Multimodal imaging in cerebral gliomas and its neuropathological correlation. Eur J Radiol 83(5):829–834

    Article  PubMed  Google Scholar 

  13. Yu A, Li K, Li H (2006) Value of diagnosis and differential diagnosis of MRI and MR spectroscopy in gliomatosis cerebri. Eur J Radiol 59(2):216–221

    Article  PubMed  Google Scholar 

  14. Desclee P, Rommel D, Hernalsteen D, Godfraind C, de Coene B, Cosnard G (2010) Gliomatosis cerebri, imaging findings of 12 cases. J Neuroradiol 37(3):148–158

    Article  PubMed  CAS  Google Scholar 

  15. Constans JM, Collet S, Kauffmann F, Hossu G, Dou W, Ruan S, Rioult F, Derlon JM, Lechapt-Zalcmann E, Chapon F, Valable S, Theron J, Guillamo JS, Courtheoux P (2011) Five-year longitudinal MRI follow-up and (1)H single voxel MRS in 14 patients with gliomatosis treated with temodal, radiotherapy and antiangiogenic therapy. Neuroradiol J 24(3):401–414

    Article  PubMed  CAS  Google Scholar 

  16. Boxerman JL, Schmainda KM, Weisskoff RM (2006) Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not. AJNR Am J Neuroradiol 27(4):859–867

    PubMed  CAS  PubMed Central  Google Scholar 

  17. Tatu L, Moulin T, Bogousslavsky J, Duvernoy H (1996) Arterial territories of human brain: brainstem and cerebellum. Neurology 47(5):1125–1135

    Article  PubMed  CAS  Google Scholar 

  18. Tatu L, Moulin T, Bogousslavsky J, Duvernoy H (1998) Arterial territories of the human brain: cerebral hemispheres. Neurology 50(6):1699–1708

    Article  PubMed  CAS  Google Scholar 

  19. Rorden C, Karnath HO, Bonilha L (2007) Improving lesion-symptom mapping. J Cogn Neurosci 19(7):1081–1088

    Article  PubMed  Google Scholar 

  20. Stummer W (2007) Mechanisms of tumor-related brain edema. Neurosurg Focus 22(5):E8

    Article  PubMed  Google Scholar 

  21. Gupta A, Young RJ, Karimi S, Sood S, Zhang Z, Mo Q, Gutin PH, Holodny AI, Lassman AB (2011) Isolated diffusion restriction precedes the development of enhancing tumor in a subset of patients with glioblastoma. AJNR Am J Neuroradiol 32(7):1301–1306

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  22. Yang S, Wetzel S, Law M, Zagzag D, Cha S (2002) Dynamic contrast-enhanced T2*-weighted MR imaging of gliomatosis cerebri. AJNR Am J Neuroradiol 23(3):350–355

    PubMed  PubMed Central  Google Scholar 

  23. Rizzo L, Crasto SG, Moruno PG, Cassoni P, Ruda R, Boccaletti R, Brosio M, De Lucchi R, Fava C (2009) Role of diffusion- and perfusion-weighted MR imaging for brain tumour characterisation. Radiol Med 114(4):645–659

    Article  PubMed  CAS  Google Scholar 

  24. Hu LS, Eschbacher JM, Dueck AC, Heiserman JE, Liu S, Karis JP, Smith KA, Shapiro WR, Pinnaduwage DS, Coons SW, Nakaji P, Debbins J, Feuerstein BG, Baxter LC (2012) Correlations between perfusion MR imaging cerebral blood volume, microvessel quantification, and clinical outcome using stereotactic analysis in recurrent high-grade glioma. AJNR Am J Neuroradiol 33(1):69–76

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  25. Wang B, Zhao P, Zhang Y, Ge M, Lan C, Li C, Pang Q, Xu S, Liu Y (2018) Quantitative dynamic susceptibility contrast perfusion-weighted imaging-guided customized gamma knife re-irradiation of recurrent high-grade gliomas. J Neurooncol 139(1):185–193

    Article  PubMed  CAS  Google Scholar 

  26. Chiang IC, Kuo YT, Lu CY, Yeung KW, Lin WC, Sheu FO, Liu GC (2004) Distinction between high-grade gliomas and solitary metastases using peritumoral 3-T magnetic resonance spectroscopy, diffusion, and perfusion imagings. Neuroradiology 46(8):619–627

    Article  PubMed  Google Scholar 

  27. Rollin N, Guyotat J, Streichenberger N, Honnorat J, Tran VM, Cotton F (2006) Clinical relevance of diffusion and perfusion magnetic resonance imaging in assessing intra-axial brain tumors. Neuroradiology 48(3):150–159

    Article  PubMed  CAS  Google Scholar 

  28. Tsougos I, Svolos P, Kousi E, Fountas K, Theodorou K, Fezoulidis I, Kapsalaki E (2012) Differentiation of glioblastoma multiforme from metastatic brain tumor using proton magnetic resonance spectroscopy, diffusion and perfusion metrics at 3 T. Cancer Imaging 12:423–436

    Article  PubMed  PubMed Central  Google Scholar 

  29. Neska-Matuszewska M, Bladowska J, Sasiadek M, Zimny A (2018) Differentiation of glioblastoma multiforme, metastases and primary central nervous system lymphomas using multiparametric perfusion and diffusion MR imaging of a tumor core and a peritumoral zone-searching for a practical approach. PLoS ONE 13(1):e0191341

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  30. Law M, Cha S, Knopp EA, Johnson G, Arnett J, Litt AW (2002) High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging. Radiology 222(3):715–721

    Article  PubMed  Google Scholar 

  31. Lehmann P, Saliou G, de Marco G, Monet P, Souraya SE, Bruniau A, Vallee JN, Ducreux D (2012) Cerebral peritumoral oedema study: does a single dynamic MR sequence assessing perfusion and permeability can help to differentiate glioblastoma from metastasis? Eur J Radiol 81(3):522–527

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alex Förster.

Ethics declarations

Conflict of interest

Alex Förster: none. Stefanie Brehmer received travel support from Carl Zeiss Meditec AG. Marcel Seiz-Rosenhagen: none. Iris Mildenberger: none. Frank A. Giordano serves as consultant and speaker for Carl Zeiss Meditec AG, NOXXON Pharma AG, Merck Serono GmbH, Roche Pharma AG, Siemens Healthcare Diagnostics GmbH, and holds patents related with Carl Zeiss Meditec AG. Holger Wenz: none. David Reuss: none. Daniel Hänggi: none. Christoph Groden: none.

Ethical approval

This study has been approved by the local institutional review board (Medizinische Ethikkommission II der Medizinischen Fakultät Mannheim) and has therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. Patient consent was waived for this analysis by the local institutional review board due to its retrospective nature.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Förster, A., Brehmer, S., Seiz-Rosenhagen, M. et al. Heterogeneity of glioblastoma with gliomatosis cerebri growth pattern on diffusion and perfusion MRI. J Neurooncol 142, 103–109 (2019). https://doi.org/10.1007/s11060-018-03068-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-018-03068-w

Keywords

Navigation